Dietary supplement carbohydrate digestion inhibitors: A review of the literature

Obesity: Epidemiology, Pathophysiology, and Prevention

Volumn , Issue , 2007, Pages 279-297

  Udani, Jay ^a   Hardy, Mary ^b   Kavoussi, Ben ^c  

^a Northridge Hospital Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Medicus Research LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72849125449     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Volek, J.S. and Feinman, R.D., Carbohydrate restriction improves the features of metabolic syndrome; metabolic syndrome may be defined by the response to carbohydrate restriction, Nutr. Metab. (Lond.), 2, 31, 2005.
2. IDF, Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, www.eatlas.idf.org.
3. AOA, AOA Fact Sheets, American Obesity Association, Washington, D.C., www.obesity.org.
4. CDC, National Diabetes Fact Sheet, Centers for Disease Control and Prevention, Atlanta, GA, www.cdc.gov/diabetes/pubs/estimates.htm.
5. 2 breath test, Gastroenterology, 96(2, Pt. 1), 503-509, 1989.
6. Wolever, T.M., Vuksan, V., Eshuis, H., Spadafora, P., Peterson, R.D. et al., Effect of method of administration of psyllium on glycemic response and carbohydrate digestibility, J. Am. Coll. Nutr., 10(4), 364-371, 1991.
7. U.S. Food and Drug Administration, In the Matter of the Complaint Against General Nutrition Corporation General Nutrition Centers, P.S. Docket No. 15/115, October 31, 1983.
8. Bo-Linn, G.W., Santa Ana, C.A., Morawski, S.G., and Fordtran, J.S., Starch blockers: their effect on calorie absorption from a high-starch meal, N. Engl. J. Med., 307(23), 1413-1416, 1982.
9. Hiele, M., Georges Brohee Prize, 1988-1989. Assimilation of nutritional carbohydrates: influence of hydrolysis, Acta Gastroenterol. Belg., 54(1), 3-11, 1991.
10. Cummings, J.H. and Englyst, H.N., Measurement of starch fermentation in the human large intestine, Can. J. Physiol. Pharmacol., 69(1), 121-129, 1991.
11. Lembcke, B., Folsch, U.R., Caspary, W.F., Ebert, R., and Creutzfeldt, W., Influence of metronidazole on the breath hydrogen response and symptoms in acarbose-induced malabsorption of sucrose, Digestion, 25(3), 186-193, 1982.
12. Hollenbeck, C.B., Coulston, A.M., Quan, R., Becker, T.R., Vreman, H.J. et al., Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies, Am. J. Clin. Nutr., 38(4), 498-503, 1983.
13. Meyer, B.H., Muller, F.O., Kruger, J.B., and Grigoleit, H.G., Inhibition of starch absorption by alphaamylase inactivator given with food, Lancet, 1(8330), 934, 1983.
14. Layer, P., Carlson, G.L., and DiMagno, E.P., Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans, Gastroenterology, 88(6), 1895-1902, 1985.
15. Layer, P., Zinsmeister, A.R., and DiMagno, E.P., Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans, Gastroenterology, 91(1), 41-48, 1986.
16. Boivin, M., Flourie, B., Rizza, R.A., Go, V.L., and DiMagno, E.P., Gastrointestinal and metabolic effects of amylase inhibition in diabetics, Gastroenterology, 94(2), 387-394, 1988.
17. Banks, W.A., Coon, A.B., Robinson, S.M., Moinuddin, A., Shultz JM. et al., Triglycerides induce leptin resistance at the blood-brain barrier, Diabetes, 53(5), 1253-1260, 2004.
18. Udani, J., Hardy, M., and Madsen, D., Use of a white bean extract for weight loss: a randomized controlled trial, in Proc. of the American Society of Bariatric Physicians Annual Meeting, Chicago, IL, October, 2003.
19. Lawton, C.L., Delargy, H.J., Brockman, J., Smith, F.C., and Blundell, J.E., The degree of saturation of fatty acids influences post-ingestive satiety, Br. J. Nutr., 83(5), 473-482, 2000.
20. 2 breath testing for the diagnosis of carbohydrate malabsorption in Italy, The Tenue Club Group, Ital. J. Gastroenterol. Hepatol., 29(2), 122-127, 1997.
21. 2 criteria, Gastroenterology, 105(5), 1404-1410, 1993.
22. Brummer, R.J., Karibe, M., and Stockbrugger, R.W., Lactose malabsorption: optimalization of investigational methods, Scand. J. Gastroenterol. Suppl., 200, 65-69, 1993.
23. Flourie, B., Florent, C., Etanchaud, F., Evard, D., Franchisseur, C., and Rambaud, J.C., Starch absorption by healthy man evaluated by lactulose hydrogen breath test, Am. J. Clin. Nutr., 47(1), 61-66, 1988.
24. 2 breath test. Dig. Dis Sci., 38(11), 2010-2016, 1993.
25. Bornet, F.R., Cloarec, D., Barry, J.L., Colonna, P., Gouilloud, S. et al., Pasta cooking time: influence on starch digestion and plasma glucose and insulin responses in healthy subjects, Am. J. Clin. Nutr., 51(3), 421-427, 1990.
26. Rumessen, J.J., Nordgaard-Andersen, I., and Gudmand-Hoyer, E., Carbohydrate malabsorption: quantification by methane and hydrogen breath tests, Scand. J. Gastroenterol., 29(9), 826-832, 1994.
27. Flourie, B., Leblond, A., Florent, C., Rautureau, M., Bisalli, A., and Rambaud, J.C., Starch malabsorption and breath gas excretion in healthy humans consuming low- and high-starch diets, Gastroenterology, 95(2), 356-363, 1988.
28. Perman, J.A., Modler, S., and Olson, A.C., Role of pH in production of hydrogen from carbohydrates by colonic bacterial flora: studies in vivo and in vitro, J. Clin. Invest., 67(3), 643-650, 1981.
29. Wolever, T.M., Cohen, Z., Thompson, L.U., Thorne, M.J., Jenkins, M.J. et al., Ileal loss of available carbohydrate in man: comparison of a breath hydrogen method with direct measurement using a human ileostomy model, Am. J. Gastroenterol., 81(2), 115-122, 1986.
30. Seifarth, C., Bergmann, J., Holst, J.J., Ritzel, R., Schmiegel, W., and Nauck, M.A., Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in type 2 diabetic patients, Diabet. Med., 15(6), 485-491, 1998.
31. Jiang, G. and Zhang, B.B., Glucagon and regulation of glucose metabolism, Am. J. Physiol. Endocrinol. Metab., 284(4), E671-E678, 2003.
32. Boivin, M., Zinsmeister, A.R., Go, V.L., and DiMagno, E.P., Effect of a purified amylase inhibitor on carbohydrate metabolism after a mixed meal in healthy humans, Mayo Clin. Proc., 62(4), 249-255, 1987.
33. Carlson, G.L., Li, B.U., Bass, P., and Olsen, W.A., A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man, Science, 219(4583), 393-395, 1983.
34. 13C-enriched starch as a tracer, Hum. Nutr. Clin. Nutr., 37(4), 301-305, 1983.
35. Jain, N.K., Boivin, M., Zinsmeister, A.R., Brown, M.L., Malagelada, and J.R., DiMagno, E.P., Effect of ileal perfusion of carbohydrates and amylase inhibitor on gastrointestinal hormones and emptying, Gastroenterology, 96(2, Pt. 1), 377-387, 1989.
36. Goncalves, O., Dintinger, T., Blanchard, D., and Tellier, C., Functional mimicry between anti-tendamistat antibodies and alpha-amylase, J. Immunol. Methods, 269(1-2), 29-37, 2002.
37. Lankisch, M., Layer, P., Rizza, R.A., and DiMagno, E.P., Acute postprandial gastrointestinal and metabolic effects of wheat amylase inhibitor (WAI) in normal, obese, and diabetic humans, Pancreas, 17(2), 176-181, 1998.
38. Meyer, B.H., Muller, F.O., Kruger, J.B., Clur, B.K., and Grigoleit, H.G., Effects of tendamistate (an alpha-amylase inactivator), guar and placebo on starch metabolism, S. Afr. Med. J., 66(6), 222-223, 1984.
39. Layer, P., Rizza, R.A., Zinsmeister, A.R., Carlson, G.L., and DiMagno, E.P., Effect of a purified amylase inhibitor on carbohydrate tolerance in normal subjects and patients with diabetes mellitus, Mayo Clin. Proc., 61(6), 442-447, 1986.
40. Vinson, J.A., Investigation on the Efficacy of Phase 2 2250, a Purified Bean Extract from Pharmachem Laboratories, University of Scranton, 2001 (unpublished).
41. Vinson, J.A., Investigation on the Efficacy of Phaseolamin2250 (Phase 2), a Purified Bean Extract from Pharmachem Laboratories, University of Scranton, 2001 (unpublished).
42. Vinson, J.A., Dose-Response Pilot Study of Phase 2 Efficacy as an Inhibitor of Glucose Absorption with a Full Meal, University of Scranton, 2002.
43. Vinson, J.A., In Vivo Effectiveness of a Starch Absorption Blocker in a Double-Blind Placebo-Controlled Study with Normal Subjects, University of Scranton, 2003.
44. Udani, J., A novel method of lowering the glycemic index of white bread using a proprietary white bean extract, in Proc. of the Scripps Integrative Medicine Conf., 2006.
45. Thom, E., A randomized, double-blind, placebo-controlled trial of a new weight-reducing agent of natural origin, J. Int. Med Res., 28(5), 229-233, 2000.
46. Effectiveness of Phase 2, a natural alpha-amylase inhibitor, for weight loss: a randomized doubleblind placebo-controlled study, in Proc. of the Scripps Clinic Natural Supplements in Evidence-Based Practice Conf., 2004.
47. Udani, J., Hardy, M., and Madsen, D.C., Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract, Altern. Med. Rev., 9(1), 63-69, 2004.
48. Anon., Starch Away Clinical Overview, 2003 (unpublished).
49. Erner, S. and Meiss, D.E., Thera-Slim for Weight Loss: A Randomized Double-Blind Placebo-Controlled Study, 2003 (unpublished).
50. Singh, B.B., Phase 2 (Phaseolus vulgaris) for Short-Term Weight Loss, 2004 (unpublished).
51. Maheshwari, R., Srimal, R., and Kuttan, R., Acute and Chronic Toxicity Studies of Phaseolamin 2250, 2002 (unpublished).
52. Lewy, V.D., Danadian, K., and Arslanian, S., Determination of body composition in African-American children: validation of bioelectrical impedance with dual energy x-ray absorptiometry, J. Pediatr. Endocrinol. Metab., 12(3), 443-448, 1999.
53. Wadden, T.A. and Berkowitz, R.I., Weight Reduction and Pride (WRAP) Program: Teen’s Edition and Parent’s Edition, University of Pennsylvania, Philadelphia, 2001
54. Gentile, S., Turco, S., Guarino, G., Sasso, F.C., and Torella, R., Aminotransferase activity and acarbose treatment in patients with type 2 diabetes, Diabetes Care, 22(7), 1217-1218, 1999.
55. Mosby’s Drug Consult, Elsevier/Mosby, Boston, MA, 2003.
56. Wolever, T.M., Jenkins, D.J., Vuksan, V., Jenkins, A.L., Buckley, G.C. et al., Beneficial effect of a low glycaemic index diet in type 2 diabetes, Diabet. Med., 9(5), 451-458, 1992.
57. Salmeron, J., Ascherio, A., Rimm, E.B., Colditz, G.A., Spiegelman, D. et al., Dietary fiber, glycemic load, and risk of NIDDM in men, Diabetes Care, 20(4), 545-550, 1997.
58. Salmeron, J., Manson, J.E., Stampfer, M.J., Colditz, G.A., Wing, A.L., and Willett, W.C., Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women, JAMA, 277(6), 472-477, 1997.
59. van Dam, R.M., Visscher, A.W., Feskens, E.J., Verhoef, P., and Kromhout, D., Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study, Eur. J. Clin. Nutr., 54(9), 726-731, 2000.
60. Wolever, T.M., Jenkins, D.J., Vuksan, V., Jenkins, A.L., Wong, G.S., and Josse, R.G., Beneficial effect of low-glycemic index diet in overweight NIDDM subjects, Diabetes Care, 15(4), 562-564, 1992.
61. Pereira, M.A., Swain, J., Goldfine, A.B., Rifai, N., and Ludwig, D.S., Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss, JAMA, 292(20), 2482-2490, 2004.
62. Boule, N.G., Haddad, E., Kenny, G.P., Wells, G.A., and Sigal, R.J., Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials, JAMA, 286(10), 1218-1227, 2001.
63. Roberts, S.B., Glycemic index and satiety, Nutr. Clin. Care, 6(1), 20-26, 2003.
64. Spieth, L.E., Harnish, J.D., Lenders, C.M., Raezer, L.B., Pereira, M.A. et al., A low-glycemic index diet in the treatment of pediatric obesity, Arch. Pediatr. Adolesc. Med., 154(9), 947-951, 2000.
65. Frost, G.S., Brynes, A.E., Bovill-Taylor, C., and Dornhorst, A., A prospective randomised trial to determine the efficacy of a low glycaemic index diet given in addition to healthy eating and weight loss advice in patients with coronary heart disease, Eur. J. Clin. Nutr., 58(1), 121-127, 2004.
66. Ebbeling, C.B., Leidig, M.M., Sinclair, K.B., Hangen, J.P., and Ludwig, D.S., A reduced-glycemic load diet in the treatment of adolescent obesity, Arch. Pediatr. Adolesc. Med., 157(8), 773-779, 2003.
67. Rasmussen, O., Lauszus, F.F., Christiansen, C., Thomsen, C., and Hermansen, K., Differential effects of saturated and monounsaturated fat on blood glucose and insulin responses in subjects with noninsulin- dependent diabetes mellitus, Am. J. Clin. Nutr., 63, 249-253, 1996.